# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-22-001401
Filing Date
2022-03-03
Accepted
2022-03-03 08:35:26
Documents
46
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | cns_i10k-123121.htm iXBRL | 10-K | 775367
2 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | cns_ex2301.htm | EX-23.1 | 2817
3 | CERTIFICATION | cns_ex3101.htm | EX-31.1 | 10002
4 | CERTIFICATION | cns_ex3102.htm | EX-31.2 | 9802
5 | CERTIFICATION | cns_ex3201.htm | EX-32.1 | 3625
6 | CERTIFICATION | cns_ex3202.htm | EX-32.2 | 3381
| Complete submission text file | 0001683168-22-001401.txt |  | 3264657

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | cnsp-20211231.xsd | EX-101.SCH | 23369
8 | XBRL CALCULATION FILE | cnsp-20211231_cal.xml | EX-101.CAL | 28454
9 | XBRL DEFINITION FILE | cnsp-20211231_def.xml | EX-101.DEF | 101311
10 | XBRL LABEL FILE | cnsp-20211231_lab.xml | EX-101.LAB | 235964
11 | XBRL PRESENTATION FILE | cnsp-20211231_pre.xml | EX-101.PRE | 181418
40 | EXTRACTED XBRL INSTANCE DOCUMENT | cns_i10k-123121_htm.xml | XML | 322753

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39126 | Film No.: 22706826
SIC: 2834 Pharmaceutical Preparations